舒血宁注射液联合阿司匹林治疗急性脑梗塞患者临床观察

Clinical observation on treating acute cerebral infarction with the Shuxuening injection plus aspirin

目的:观察舒血宁注射液联合阿司匹林对急性脑梗塞的临床治疗效果。方法:选取90例急性脑梗塞,按照随机平均的方法分为两组,分别为实验组和对照组,每组45例。实验组45例采取舒血宁注射液联合阿司匹林治疗,对照组45例采取丹参注射液治疗。两周后对两组患者的临床治疗效果、神经功能受损评分(NFDS)、日常生活能力(Barthel)指数进行比较。结果:实验组的总有效率为88.9%,而对照组为64.4%,两组间具有显著性差异(P<0.05)。治疗后实验组NFDS评分和Barthel指数与对照组相比具有显著性差异(P<0.05)。用药后两组患者均未出现不良反应。结论:舒血宁注射液联合阿司匹林可促进急性脑梗塞患者受损神经的功能恢复,改善其生活质量,具有良好的临床效果。

Objective： To observe the Shuxuening injection plus aspirin for acute cerebral infarction. Methods： 90 cases of acute cerebral infarction were randomly divided into two groups, 45 cases for each. In the experimental group, 45 patients took the Shuxuening injection plus aspirin; the control group took the Danshen injection. Results： In the experimental group, the total efficiency was 88.9%, while in the control group it was 64.4%,（P〈0.05）. In the experimental group, NFDS score and Barthel index were different from those in the control group, with significant difference（P〈0.05） after treatment. Conclusion： The Shuxuening injection plus aspirin for acute cerebral infarction may promote functional recovery of damaged nerves, improve their quality of life.